Saliu, T.P.; Yazawa, N.; Hashimoto, K.; Miyata, K.; Kudo, A.; Horii, M.; Kamesawa, M.; Kumrungsee, T.; Yanaka, N.
Serum Amyloid A3 Promoter-Driven Luciferase Activity Enables Visualization of Diabetic Kidney Disease. Int. J. Mol. Sci. 2022, 23, 899.
https://doi.org/10.3390/ijms23020899
AMA Style
Saliu TP, Yazawa N, Hashimoto K, Miyata K, Kudo A, Horii M, Kamesawa M, Kumrungsee T, Yanaka N.
Serum Amyloid A3 Promoter-Driven Luciferase Activity Enables Visualization of Diabetic Kidney Disease. International Journal of Molecular Sciences. 2022; 23(2):899.
https://doi.org/10.3390/ijms23020899
Chicago/Turabian Style
Saliu, Tolulope Peter, Nao Yazawa, Kotaro Hashimoto, Kenshu Miyata, Ayane Kudo, Mayu Horii, Mion Kamesawa, Thanutchaporn Kumrungsee, and Noriyuki Yanaka.
2022. "Serum Amyloid A3 Promoter-Driven Luciferase Activity Enables Visualization of Diabetic Kidney Disease" International Journal of Molecular Sciences 23, no. 2: 899.
https://doi.org/10.3390/ijms23020899
APA Style
Saliu, T. P., Yazawa, N., Hashimoto, K., Miyata, K., Kudo, A., Horii, M., Kamesawa, M., Kumrungsee, T., & Yanaka, N.
(2022). Serum Amyloid A3 Promoter-Driven Luciferase Activity Enables Visualization of Diabetic Kidney Disease. International Journal of Molecular Sciences, 23(2), 899.
https://doi.org/10.3390/ijms23020899